S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis

Basal cell carcinoma is the most common malignant tumor among fair-skinned individuals, and its incidence has been rising steadily in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 1 highlights new developments in genetics in particular as well as aspects regarding epidemiology, diagnosis, and histology.

Brief S2k guidelines - Merkel cell carcinoma

Jurgen C. Becker, Chalid Assaf, Dirk Vordermark, Sven N. Reske, Jorg Hense, Therese Dettenborn, Oliver Seitz, Stephan Grabbe (1) Division of General Dermatology, Graz University Hospital, Austria (2) Department of Dermatology, HELIOS Klinikum, Krefeld, Germany (3) Department of Radiotherapy, University Hospital Halle (Saale), Germany (4) Department of Nuclear Medicine, University Hospital Ulm, Germany (5) Department of Internal Medicine, University Hospital Essen, Germany (6) Department of Plastic Surgery, Hornheide Clinic, Munster, Germany (7) Department of Oral and Maxillofacial Surgery, University of Frankfurt Hospital, Germany (8) Department of Dermatology, Mainz University Hospital, Ge…

S3-Leitlinie "Diagnostik, Therapie und Nachsorge des Melanoms" - Kurzfassung

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up

Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

Malignant Melanoma S3-Guideline “Diagnosis, Therapy and Follow-up of Melanoma”

This first German evidence-based guideline for cutaneous melanoma was developed under the auspices of the German Dermatological Society (DDG) and the Dermatologic Cooperative Oncology Group (DeCOG) and funded by the German Guideline Program in Oncology. The recommendations are based on a systematic literature search, and on the consensus of 32 medical societies, working groups and patient representatives. This guideline contains recommendations concerning diagnosis, therapy and follow-up of melanoma. The diagnosis of primary melanoma based on clinical features and dermoscopic criteria. It is confirmed by histopathologic examination after complete excision with a small margin. For the stagin…